Enhabit, Inc. (NYSE:EHAB) Shares Acquired by Jane Street Group LLC

Jane Street Group LLC lifted its holdings in shares of Enhabit, Inc. (NYSE:EHAB - Free Report) by 514.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 901,084 shares of the company's stock after buying an additional 754,395 shares during the quarter. Jane Street Group LLC owned approximately 1.79% of Enhabit worth $7,119,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Systematic Financial Management LP grew its holdings in shares of Enhabit by 12.2% during the third quarter. Systematic Financial Management LP now owns 1,838,199 shares of the company's stock worth $14,522,000 after buying an additional 199,235 shares in the last quarter. Point72 DIFC Ltd purchased a new position in Enhabit during the third quarter worth approximately $108,000. Needham Investment Management LLC increased its position in Enhabit by 42.9% during the third quarter. Needham Investment Management LLC now owns 50,000 shares of the company's stock worth $395,000 after purchasing an additional 15,000 shares during the last quarter. Atom Investors LP increased its holdings in shares of Enhabit by 47.5% during the 3rd quarter. Atom Investors LP now owns 173,783 shares of the company's stock worth $1,373,000 after buying an additional 55,999 shares during the last quarter. Finally, Bardin Hill Management Partners LP increased its stake in Enhabit by 927.4% during the third quarter. Bardin Hill Management Partners LP now owns 174,304 shares of the company's stock worth $1,377,000 after acquiring an additional 157,338 shares during the last quarter.

Enhabit Price Performance

EHAB remained flat at $8.52 on Friday. The company's stock had a trading volume of 207,556 shares, compared to its average volume of 571,605. Enhabit, Inc. has a 12-month low of $6.85 and a 12-month high of $11.74. The stock's 50-day moving average is $7.56 and its 200 day moving average is $8.30. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.46 and a quick ratio of 1.46. The firm has a market cap of $428.42 million, a PE ratio of -3.67 and a beta of 1.89.

Enhabit (NYSE:EHAB - Get Free Report) last issued its quarterly earnings results on Wednesday, November 6th. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.04 by ($0.01). The company had revenue of $253.60 million for the quarter, compared to analyst estimates of $261.69 million. Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. During the same period in the prior year, the business earned $0.03 earnings per share. On average, research analysts anticipate that Enhabit, Inc. will post 0.22 EPS for the current year.

Insider Transactions at Enhabit

In other news, Director Jeffrey Bolton bought 4,000 shares of the stock in a transaction on Thursday, December 12th. The shares were bought at an average price of $8.69 per share, with a total value of $34,760.00. Following the completion of the acquisition, the director now owns 98,144 shares of the company's stock, valued at approximately $852,871.36. This trade represents a 4.25 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Stuart M. Mcguigan purchased 15,000 shares of the business's stock in a transaction dated Tuesday, December 10th. The shares were purchased at an average cost of $8.81 per share, with a total value of $132,150.00. Following the purchase, the director now directly owns 46,810 shares in the company, valued at approximately $412,396.10. The trade was a 47.15 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 1.90% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the stock. Leerink Partners reaffirmed a "market perform" rating and set a $8.00 target price (down previously from $8.50) on shares of Enhabit in a research note on Tuesday, November 19th. Jefferies Financial Group upgraded shares of Enhabit from a "hold" rating to a "buy" rating and lifted their price objective for the company from $8.25 to $9.50 in a report on Monday, December 9th. One research analyst has rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, Enhabit currently has a consensus rating of "Hold" and a consensus price target of $8.75.

Enhabit Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.